IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
69
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Icecure Medical Ltd market cap is $2.5M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Icecure Medical Ltd 52 week high is $22.50 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Icecure Medical Ltd 52 week low is $0.65 as of November 15, 2026.
Icecure Medical Ltd stock price today is $0.73.
Icecure Medical Ltd stock price yesterday was $0.7005.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Icecure Medical Ltd's P/E ratio is -0.11.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Icecure Medical Ltd P/B ratio is 0.2103.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Icecure Medical Ltd 50-day moving average is $1.35.
